Viewing Study NCT07158151


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2025-12-25 @ 9:33 PM
Study NCT ID: NCT07158151
Status: RECRUITING
Last Update Posted: 2025-11-19
First Post: 2025-08-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
Sponsor: Reistone Biopharma Company Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module